Loading...
OTCM
JRSS
Market cap1mUSD
Jul 09, Last price  
0.02USD
IPO
-96.49%
Name

JRsis Health Care Corp

Chart & Performance

D1W1MN
OTCM:JRSS chart
P/E
196.72
P/S
5.42
EPS
0.00
Div Yield, %
Shrs. gr., 5y
35.87%
Rev. gr., 5y
-61.05%
Revenues
320k
-75.83%
4,351,2365,979,61011,872,40318,118,74524,147,95728,402,75931,463,43335,706,19744,391,17189,1663,461,9331,324,863320,212
Net income
9k
P
399,977611,4941,790,7133,471,8684,646,8901,992,970888,0612,679,0952,232,261-33,721,300-80,912-509,7908,816
CFO
-136k
L-69.07%
993,2142,054,1832,531,6394,986,4668,338,2109,199,13411,847,40310,643,0178,233,0163,066,645516,724-438,313-135,551

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in 2006, JRSIS Health Care Corporation, originally named China Runteng Medical Group Co., Ltd until its rebranding in November 2013, operates from Harbin in China's Heilongjiang Province. The corporation specializes in delivering a broad spectrum of medical services. These include pediatrics, dermatology, otolaryngology (ears, nose, and throat), traditional Chinese medicine, ophthalmology, internal medicine, dentistry, general surgery, rehabilitation sciences, and gynecology, alongside various general healthcare provisions. JRSIS facilitates these services primarily through Jiarun Hospital, a substantial medical facility equipped with 950 patient beds.
IPO date
Mar 06, 2014
Employees
3
Domiciled in
CN
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT